Literature DB >> 16724113

Myc influences global chromatin structure.

Paul S Knoepfler1, Xiao-yong Zhang, Pei Feng Cheng, Philip R Gafken, Steven B McMahon, Robert N Eisenman.   

Abstract

The family of myc proto-oncogenes encodes transcription factors (c-, N-, and L-Myc) that regulate cell growth and proliferation and are involved in the etiology of diverse cancers. Myc proteins are thought to function by binding and regulating specific target genes. Here we report that Myc proteins are required for the widespread maintenance of active chromatin. Disruption of N-myc in neuronal progenitors and other cell types leads to nuclear condensation accompanied by large-scale changes in histone modifications associated with chromatin inactivation, including hypoacetylation and altered methylation. These effects are largely reversed by exogenous Myc as well as by differentiation and are mimicked by the Myc antagonist Mad1. The first chromatin changes are evident within 6 h of Myc loss and lead to changes in chromatin structure. Myc widely influences chromatin in part through upregulation of the histone acetyltransferase GCN5. This study provides the first evidence for regulation of global chromatin structure by an oncoprotein and may explain the broad effects of Myc on cell behavior and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16724113      PMCID: PMC1500848          DOI: 10.1038/sj.emboj.7601152

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  63 in total

Review 1.  Deconstructing myc.

Authors:  R N Eisenman
Journal:  Genes Dev       Date:  2001-08-15       Impact factor: 11.361

Review 2.  Chromatin goes global.

Authors:  S L Berger; G Felsenfeld
Journal:  Mol Cell       Date:  2001-08       Impact factor: 17.970

Review 3.  Transcriptional repression, apoptosis, human disease and the functional evolution of the nuclear lamina.

Authors:  M Cohen; K K Lee; K L Wilson; Y Gruenbaum
Journal:  Trends Biochem Sci       Date:  2001-01       Impact factor: 13.807

4.  Modulation of T-lymphocyte development, growth and cell size by the Myc antagonist and transcriptional repressor Mad1.

Authors:  Brian M Iritani; Jeffrey Delrow; Carla Grandori; Ivan Gomez; Meredith Klacking; Leni Sue Carlos; Robert N Eisenman
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

5.  Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain.

Authors:  A J Bannister; P Zegerman; J F Partridge; E A Miska; J O Thomas; R C Allshire; T Kouzarides
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

6.  Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins.

Authors:  M Lachner; D O'Carroll; S Rea; K Mechtler; T Jenuwein
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

7.  Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein.

Authors:  Xiao-Yong Zhang; Lauren M DeSalle; Jagruti H Patel; Anthony J Capobianco; Duonan Yu; Andrei Thomas-Tikhonenko; Steven B McMahon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

8.  Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation.

Authors:  S R Frank; M Schroeder; P Fernandez; S Taubert; B Amati
Journal:  Genes Dev       Date:  2001-08-15       Impact factor: 11.361

Review 9.  Contributions of Myc to tumorigenesis.

Authors:  Werner Lutz; Javier Leon; Martin Eilers
Journal:  Biochim Biophys Acta       Date:  2002-03-14

10.  Quantitative proteomic analysis of Myc oncoprotein function.

Authors:  Yuzuru Shiio; Sam Donohoe; Eugene C Yi; David R Goodlett; Ruedi Aebersold; Robert N Eisenman
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

View more
  199 in total

1.  myc maintains embryonic stem cell pluripotency and self-renewal.

Authors:  Natalia V Varlakhanova; Rebecca F Cotterman; Wilhelmine N deVries; Judy Morgan; Leah Rae Donahue; Stephen Murray; Barbara B Knowles; Paul S Knoepfler
Journal:  Differentiation       Date:  2010-05-27       Impact factor: 3.880

2.  Epigenetic reprogramming of Myc target genes.

Authors:  Stefano Amente; Luigi Lania; Barbara Majello
Journal:  Am J Cancer Res       Date:  2011-02-06       Impact factor: 6.166

Review 3.  MYC as a regulator of ribosome biogenesis and protein synthesis.

Authors:  Jan van Riggelen; Alper Yetil; Dean W Felsher
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

Review 4.  Higher-order genome organization in human disease.

Authors:  Tom Misteli
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-30       Impact factor: 10.005

5.  Differences between cellular and molecular profiles of induced pluripotent stem cells generated from mouse embryonic fibroblasts.

Authors:  Eun Young Kim; Kilsoo Jeon; Hyo Young Park; Young Joon Han; Byoung Chul Yang; Soo Bong Park; Hyung Min Chung; Se Pill Park
Journal:  Cell Reprogram       Date:  2010-10-19       Impact factor: 1.987

Review 6.  MYC: connecting selective transcriptional control to global RNA production.

Authors:  Theresia R Kress; Arianna Sabò; Bruno Amati
Journal:  Nat Rev Cancer       Date:  2015-09-18       Impact factor: 60.716

7.  Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism.

Authors:  David N Boone; Ying Qi; Zhaoliang Li; Stephen R Hann
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

8.  c-Myc-dependent formation of Robertsonian translocation chromosomes in mouse cells.

Authors:  Amanda Guffei; Zelda Lichtensztejn; Amanda Gonçalves Dos Santos Silva; Sherif F Louis; Andrea Caporali; Sabine Mai
Journal:  Neoplasia       Date:  2007-07       Impact factor: 5.715

9.  Sustained in vitro trigger of self-renewal divisions in Hoxb4hiPbx1(10) hematopoietic stem cells.

Authors:  Sonia Cellot; Jana Krosl; Jalila Chagraoui; Sylvain Meloche; R Keith Humphries; Guy Sauvageau
Journal:  Exp Hematol       Date:  2007-05       Impact factor: 3.084

10.  SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease.

Authors:  Jiyung Shin; Ming He; Yufei Liu; Silvana Paredes; Lidia Villanova; Katharine Brown; Xiaolei Qiu; Noushin Nabavi; Mary Mohrin; Kathleen Wojnoonski; Patrick Li; Hwei-Ling Cheng; Andrew J Murphy; David M Valenzuela; Hanzhi Luo; Pankaj Kapahi; Ronald Krauss; Raul Mostoslavsky; George D Yancopoulos; Frederick W Alt; Katrin F Chua; Danica Chen
Journal:  Cell Rep       Date:  2013-11-07       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.